Fisetin caused the induction of apoptosis in bladder cancer, and it is initiated through the regulation of two related pathways, the downregulation of the NF-κB pathway and the upregulation of p53 activity, initiating changes in the ratio of pro- and antiapoptotic proteins. Here, NFKB1 is linked to urinary bladder carcinoma.